Cabot (NYSE:CBT) Stock Rating Upgraded by UBS Group

by · The Markets Daily

Cabot (NYSE:CBT – Get Free Report) was upgraded by equities research analysts at UBS Group from a “hold” rating to a “strong-buy” rating in a research note issued on Thursday, MarketBeat Ratings reports.

Several other equities research analysts have also weighed in on CBT. Jefferies Financial Group reissued a “buy” rating and issued a $81.00 price objective on shares of Cabot in a report on Thursday. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Mizuho boosted their price target on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. JPMorgan Chase & Co. dropped their price target on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $74.00.

Check Out Our Latest Stock Analysis on Cabot

Cabot Stock Up 1.4%

Cabot stock opened at $72.80 on Thursday. The firm has a 50 day moving average price of $64.88 and a 200-day moving average price of $72.29. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50. Cabot has a twelve month low of $58.33 and a twelve month high of $92.89. The company has a market capitalization of $3.85 billion, a P/E ratio of 12.11, a P/E/G ratio of 3.76 and a beta of 0.89.

Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same quarter in the previous year, the company posted $1.80 EPS. Cabot’s revenue for the quarter was down 10.2% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities analysts predict that Cabot will post 7.57 EPS for the current year.

Institutional Investors Weigh In On Cabot

A number of institutional investors and hedge funds have recently made changes to their positions in CBT. Gabelli Funds LLC increased its stake in Cabot by 1.3% in the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after acquiring an additional 180 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Cabot by 1.7% during the second quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company’s stock worth $791,000 after purchasing an additional 181 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 189 shares during the last quarter. Ferguson Wellman Capital Management Inc. lifted its position in Cabot by 4.2% during the second quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock valued at $375,000 after purchasing an additional 200 shares during the last quarter. Finally, First Citizens Bank & Trust Co. lifted its position in Cabot by 1.4% during the third quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock valued at $1,107,000 after purchasing an additional 206 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading